A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

551

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

PD 0332334

Capsules, oral, 300 mg BID, 8 weeks with 2 week taper.

DRUG

Placebo

Capsules, oral, placebo BID, 8 weeks with 2 week taper.

DRUG

PD 0332334

Capsules, oral, 225 mg BID, 8 weeks with 2 week taper.

DRUG

PD 0332334

Capsules, oral, 175 mg BID, 8 weeks with 2 week taper.

Trial Locations (43)

10024

Pfizer Investigational Site, New York

10312

Pfizer Investigational Site, Staten Island

11201

Pfizer Investigational Site, Brooklyn

19139

Pfizer Investigational Site, Philadelphia

19149

Pfizer Investigational Site, Philadelphia

20852

Pfizer Investigational Site, Rockville

21061

Pfizer Investigational Site, Glen Burnie

23230

Pfizer Investigational Site, Richmond

27514

Pfizer Investigational Site, Chapel Hill

27710

Pfizer Investigational Site, Durham

29407

Pfizer Investigational Site, Charleston

30060

Pfizer Investigational Site, Marietta

30308

Pfizer Investigational Site, Atlanta

30328

Pfizer Investigational Site, Atlanta

32216

Pfizer Investigational Site, Jacksonville

32806

Pfizer Investigational Site, Orlando

33407

Pfizer Investigational Site, West Palm Beach

33613

Pfizer Investigational Site, Tampa

42301

Pfizer Investigational Site, Owensboro

43210

Pfizer Investigational Site, Columbus

47905

Pfizer Investigational Site, Lafayette

48336

Pfizer Investigational Site, Farmington Hills

53562

Pfizer Investigational Site, Middleton

60048

Pfizer Investigational Site, Libertyville

60194

Pfizer Investigational Site, Schaumburg

70601

Pfizer Investigational Site, Lake Charles

77057

Pfizer Investigational Site, Houston

90210

Pfizer Investigational Site, Beverly Hills

91316

Pfizer Investigational Site, Encino

91403

Pfizer Investigational Site, Sherman Oaks

91950

Pfizer Investigational Site, National City

92103

Pfizer Investigational Site, San Diego

97210

Pfizer Investigational Site, Portland

98104

Pfizer Investigational Site, Seattle

92660-2452

Pfizer Investigational Site, Newport Beach

06030-6415

Pfizer Investigational Site, Farmington

32256-2006

Pfizer Investigational Site, Jacksonville

02478

Pfizer Investigational Site, Belmont

02721

Pfizer Investigational Site, Fall River

03060

Pfizer Investigational Site, Nashua

08002

Pfizer Investigational Site, Cherry Hill

08854-5635

Pfizer Investigational Site, Piscataway

02865

Pfizer Investigational Site, Lincoln

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY